#1 Startup Dataset
Growth rates, revenue data, direct competitors and contact details.
Hua Zheng Email
SVP & Head Global Regulatory Affairs . AnHeart Therapeutics
How to contact Hua Zheng
Join and see Hua's contact info for free!Current Roles
Employees:
46Revenue:
$7.1MAbout
AnHeart Therapeutics is an oncology-focused clinical stage biopharmaceutical company headquartered in Hangzhou, China with offices in Beijing, Shanghai and New York. The company’s pipeline consists of three clinical stage assets: Taletrectinib, a next-gen ROS1 and NTRK inhibitor currently in Phase 2; an mIDH1 inhibitor ready for Phase 2 for low grade glioma, cholangiocarcinoma, AML and other tumors; and an AXL inhibitor in Phase 1 for overcoming resistance in various tumors.AnHeart Therapeutics Address
777 Third AvenueShanghai, NY
United States